The objective of 3D bioprinting is to fabricate living volumetric constructs through the sequential deposition of materials harboring living cells, known as bioinks. This bioink is not only central but also the distinctive feature that demarcates "bioprinting" from "3D printing." The efficacy in generating functional tissues is profoundly influenced by the quality of the bioink. The biomaterial ink's composition and the mechanisms of network crosslinking are pivotal in determining the mechanical, physicochemical, and biological properties of the resultant 3D constructs. Natural-origin carbohydrates, such as alginate, gelatin, and hyaluronic acid, have been extensively utilized in 3D bioprinting due to their versatility, biodegradability, biocompatibility, lack of immunogenicity, and, in certain instances, their structural resemblance to the decellularized extracellular matrix (ECM) of native tissues.
CD BioGlyco is at the forefront of this innovative field and leverages the unique properties of natural-origin carbohydrates to create a bioink that not only meets but exceeds the stringent requirements of 3D bioprinting. Based on the advanced GlycoNano™ Platform, we provide a comprehensive solution that offers a diverse range of bioinks derived from various natural-origin carbohydrates. Each bioink is meticulously designed to cater to specific needs in 3D bioprinting, ensuring optimal performance in terms of printability, mechanical properties, and biological functionality.
The production of carbohydrate base material bioink involves several critical steps, from the synthesis of the carbohydrate base material to the formulation of the bioink and its characterization.
We prepare the carbohydrate base material, which serves as the foundational component of the bioink, by dissolving it in a suitable aqueous solution. This solution is stirred overnight at room temperature to ensure complete dissolution. Other bioink components, such as crosslinking agents, stabilizers, and additional structural components, are prepared in their respective forms, either as powders or solutions.
We culture specific cell lines in a medium conducive to cell growth, supplemented with necessary nutrients. The cells are then harvested using enzymatic digestion and centrifugation to obtain a concentrated cell pellet. The cell pellet is resuspended in a serum-free medium and subsequently mixed with other bioink excipients to formulate the bioink.
The bioink formulation is prepared in separate vials under sterile conditions. Each vial contains different components of the bioink, including the dissolved carbohydrate base material, crosslinking agents, and a mixture of cells and structural components. We mix the carbohydrate base material and crosslinking agents to create a neutral solution, which is then subjected to centrifugation to remove air bubbles. This neutral solution is then combined with the remaining components and homogeneously mixed to obtain the final bioink formulation.
DOI: 10.3389/fmats.2019.00179
Journal: Biomaterials Research
Published: 2023
IF: 8.1
Result: The authors of this review discuss the use of hyaluronic acid and its derivatives as bioinks in 3D bioprinting for tissue regeneration and biomedical engineering. They cover the modification and cross-linking methods of hyaluronic acid, evaluate the strengths and limitations of these methods, and review the practical clinical applications and outcomes of hyaluronic acid bioinks. The review also identifies the challenges and opportunities in the development of hyaluronic acid bioinks, providing insights and references for future research.
At CD BioGlyco, our GlycoNano™ Bioink Production Service is poised to revolutionize the way functional tissues are created, offering researchers and clinicians unprecedented control and versatility in their work. If you want to push the boundaries of 3D bioprinting by delivering bioinks that set new standards in precision, reliability, and performance, contact us!
Reference